ArticleAntimicrobial agents and chemotherapy2017
Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?"
Lucy Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.